These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35748825)

  • 1. Editorial: optimising hepatitis B vaccine response in inflammatory bowel disease-time to get some skin in the game. Authors' reply.
    Ko KL; Hung IF; Leung WK
    Aliment Pharmacol Ther; 2022 Jul; 56(2):355-356. PubMed ID: 35748825
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial: optimising hepatitis B vaccine response in inflammatory bowel disease-time to get some skin in the game.
    Gill M; Majumdar A
    Aliment Pharmacol Ther; 2022 Jul; 56(2):353-354. PubMed ID: 35748830
    [No Abstract]   [Full Text] [Related]  

  • 3. Editorial: COVID-19 vaccines are safe and effective in patients with inflammatory bowel disease-but many unanswered questions remain. Authors' reply.
    Bhurwal A; Mutneja H; Seril D
    Aliment Pharmacol Ther; 2022 Jul; 56(1):164-165. PubMed ID: 35689313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Editorial: natural history of irritable bowel syndrome in inflammatory bowel disease-authors' reply.
    Fairbrass KM; Hamlin PJ; Gracie DJ; Ford AC
    Aliment Pharmacol Ther; 2022 Oct; 56(8):1302-1303. PubMed ID: 36168260
    [No Abstract]   [Full Text] [Related]  

  • 5. Lower response to the hepatitis B vaccine in future inflammatory bowel disease patients.
    Ardesia M; Costantino G; Fries W
    Eur J Gastroenterol Hepatol; 2016 Sep; 28(9):1101-2. PubMed ID: 27465348
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hepatitis B vaccine and inflammatory bowel disease].
    Castells L
    Med Clin (Barc); 2009 Mar; 132(9):348-50. PubMed ID: 19268979
    [No Abstract]   [Full Text] [Related]  

  • 7. Sci-B-VacTM Vs ENGERIX-B Vaccines for Hepatitis B Virus in Patients with Inflammatory Bowel Diseases: A Randomised Controlled Trial.
    Etzion O; Novack V; Perl Y; Abel O; Schwartz D; Munteanu D; Abufreha N; Ben-Yaakov G; Maoz ED; Moshaklo A; Dizingf V; Fich A
    J Crohns Colitis; 2016 Aug; 10(8):905-12. PubMed ID: 26928962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenecity of hepatitis A and B vaccination in pediatric patients with inflammatory bowel disease.
    Urganci N; Kalyoncu D
    J Pediatr Gastroenterol Nutr; 2013 Apr; 56(4):412-15. PubMed ID: 23841120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of hepatitis B vaccine in patients with inflammatory bowel disease and the benefits of revaccination.
    Cossio-Gil Y; Martínez-Gómez X; Campins-Martí M; Rodrigo-Pendás JÁ; Borruel-Sainz N; Rodríguez-Frías F; Casellas-Jordà F
    J Gastroenterol Hepatol; 2015 Jan; 30(1):92-8. PubMed ID: 25160690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editorial: investigating the association between sweetened beverages and risk of inflammatory bowel disease-authors' reply.
    Fu T; Wang X; Chen J
    Aliment Pharmacol Ther; 2022 Sep; 56(6):1088-1089. PubMed ID: 35995740
    [No Abstract]   [Full Text] [Related]  

  • 11. Editorial: measuring disease severity in inflammatory bowel disease-the whole is greater than the sum of its parts. Authors' reply.
    Swaminathan A; Mules TC; Gearry RB
    Aliment Pharmacol Ther; 2022 Aug; 56(4):746-747. PubMed ID: 35879891
    [No Abstract]   [Full Text] [Related]  

  • 12. Editorial: progress towards more comprehensively understanding the sources of corticosteroids for patients with inflammatory bowel disease-authors' reply.
    Rosiou K; Selinger CP
    Aliment Pharmacol Ther; 2022 Sep; 56(5):898-899. PubMed ID: 35934863
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial: can we get more clinical benefit from thiopurine metabolite testing? Authors' reply.
    Wong DR; Hooymans PM
    Aliment Pharmacol Ther; 2017 Mar; 45(6):858-859. PubMed ID: 28211625
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial: rising rates of venous thromboembolism among hospitalised patients with inflammatory bowel disease in the USA-authors' reply.
    Lee KE; Faye AS
    Aliment Pharmacol Ther; 2022 Oct; 56(7):1213-1214. PubMed ID: 36071009
    [No Abstract]   [Full Text] [Related]  

  • 15. Editorial: concurrence of coeliac disease with inflammatory bowel disease - is big data the final arbiter? Authors' reply.
    Sonnenberg A; Genta RM
    Aliment Pharmacol Ther; 2023 May; 57(10):1155-1156. PubMed ID: 37094326
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial: anti-TNF agents against vedolizumab as a second-line treatment? Not surprising tie game-authors' reply.
    Rundquist S; Sachs MC; Eriksson C; Olén O; Montgomery S; Halfvarson J
    Aliment Pharmacol Ther; 2021 Mar; 53(5):642-643. PubMed ID: 33566420
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatitis-B Vaccine Response in Inflammatory Bowel Disease Patients: A Systematic Review and Meta-analysis.
    Kochhar GS; Mohan BP; Khan SR; Chandan S; Kassab LL; Ponnada S; Desai A; Caldera F; Dulai PS; Farraye FA
    Inflamm Bowel Dis; 2021 Oct; 27(10):1610-1619. PubMed ID: 33393585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving Hepatitis B Virus Vaccination Responses in Inflammatory Bowel Disease: Does Greater Dose and Greater Frequency Lead to Greater Protection?
    Banty A; Melmed GY
    Am J Gastroenterol; 2020 Nov; 115(11):1797-1798. PubMed ID: 33156097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of immunosuppressive therapy on hepatitis B vaccination in inflammatory bowel diseases.
    Belle A; Baumann C; Bigard MA; Zallot C; Gizard E; Guéant JL; Bronowicki JP; Peyrin-Biroulet L
    Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):877-81. PubMed ID: 26121376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three vs Four Dose Schedule of Hepatitis-B Vaccine in HIV-infected Children: Authors' Reply.
    Dewan P
    Indian Pediatr; 2021 May; 58(5):493-494. PubMed ID: 33980739
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.